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Abstract Biocompatible magnetic nanoparticles hold
great therapeutic potential, but conventional particles can
be toxic. Here, we report the synthesis and alternating
magnetic ﬁeld dependent actuation of a remotely control-
lable, multifunctional nano-scale system and its marked
biocompatibility with mammalian cells. Monodisperse,
magnetic nanospheres based on thermo-sensitive polymer
network poly(ethylene glycol) ethyl ether methacrylate-co-
poly(ethylene glycol) methyl ether methacrylate were
synthesized using free radical polymerization. Synthesized
nanospheres have oscillating magnetic ﬁeld induced
thermo-reversible behavior; exhibiting desirable charac-
teristics comparable to the widely used poly-N-iso-
propylacrylamide-based systems in shrinkage plus a
broader volumetric transition range. Remote heating and
model drug release were characterized for different ﬁeld
strengths. Nanospheres containing nanoparticles up to an
iron concentration of 6 mM were readily taken up by
neuron-like PC12 pheochromocytoma cells and had
reduced toxicity compared to other surface modiﬁed
magnetic nanocarriers. Furthermore, nanosphere exposure
did not inhibit the extension of cellular processes (neurite
outgrowth) even at high iron concentrations (6 mM),
indicating minimal negative effects in cellular systems.
Excellent intracellular uptake and enhanced biocompati-
bility coupled with the lack of deleterious effects on neurite
outgrowth and prior Food and Drug Administration (FDA)
approval of PEG-based carriers suggest increased thera-
peutic potential of this system for manipulating axon
regeneration following nervous system injury.
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Introduction
Treatment potential for many biomedical conditions is
limited by the lack of therapeutics that can be efﬁciently
targeted and precisely controlled. For instance, functional
recovery following neurotraumatic injury could be facili-
tated by therapeutics for guided axon regeneration [1].
Axon growth can be directed by magnetic or electrical
ﬁelds alone [2–4], but a more manipulable system that
provides precisely tunable therapeutic delivery may offer
enhanced potential to direct axon regeneration and guid-
ance to targets. Nano-structured materials and smart sur-
faces provide great potential for developing such novel
biomedical therapeutics [5–8]. However, several issues
limit the use of conventional magnetic nanoparticles for
biomedical applications. Magnetic nanoparticles alone are
highly toxic, but excipients can facilitate their delivery to
cells [9]. Several groups have synthesized magnetic
S. Ghosh (&)
Department of Physics and Engineering Physics, Southeast
Missouri State University, MS 6600, One University Plaza,
Cape Girardeau, MO 63701, USA
e-mail: sghosh@semo.edu
S. GhoshMitra   N. C. Mills   D. L. Hynds
Department of Biology, Texas Woman’s University,
PO Box 425799, Denton, TX 76204, USA
T. Cai
Department of Physics, University of North Texas, Denton,
TX 76203, USA
D. R. Diercks
Center of Advancement of Research and Technology,
University of North Texas, Denton, TX 76207, USA
123
Nanoscale Res Lett (2010) 5:195–204
DOI 10.1007/s11671-009-9465-9nanoparticle systems using smart polymers like poly
(N-isopropylacrylamide) (PNIPAM) [10–12]. However,
PNIPAM based systems have low biocompatibility because
the NIPAM monomer is carcinogenic and teratogenic [13].
Dimercaptosuccinic acid (DMSA) coated particles enhan-
ces intracellular uptake, but the surface functionalization
does not improve the biocompatibility of the nanomagnets
[14]. Traditional polyethylene glycol (PEG) coating redu-
ces toxicity, but it does not retain thermo-sensitive
behavior or external tunability. Thus, development of a
highly biocompatible, non-toxic and highly tunable nano-
particle system is necessary. Ideally, the constructed
materials should: (1) minimize toxicity, (2) control intra-
cellular functions like temperature or pH, and (3) elicit a
fast response to external stimuli (e.g., ac magnetic ﬁeld). A
system that meets these goals possesses enhanced potential
for combinatorial therapeutics. For example, simultaneous
use of hyperthermia and low doses of chemotherapeutic
agents decreases tumor growth by targeted cytotoxicity
with reduced systemic effects [15].
For axon regeneration, a system that allows manipulation
of cellular function or delivery of drugs through regulation
of temperature and/or magnetic ﬁelds may be ideal. PNI-
PAM coated nanomagnets are attractive because of their
perceived intelligence to external stimuli. For instance, they
have a lower critical solution temperature (LCST) close to
the normal physiological temperature (*33 C), allowing
size tunability and therefore controlled release of small
molecules around 33–35 C[ 16]. However, it is necessary
to tune the LCST in the range of 33–42 C for certain
biomedical applications requiring volumetric transition at
higher temperatures. Recently, LCSTs of polyethylene
glycol (PEG) based systems have been tailored between 24
and42 Cbychangingthe molarratioandmolecularweight
of the copolymers [17, 18]. It is also possible to regulate
pressure/ﬂow/temperature inmicrometerorsub-micrometer
range by using tunable magnetic nanocrystals embedded in
thermo-sensitive polymer networks [19]. Since PEG is non-
toxic, anti-immunogenic and approved by the FDA [9, 17],
the potential of magnetic modulation makes it an attractive
alternative for overcoming traditional difﬁculties in actu-
ating conventional micro- or nano-structures using chemi-
cal, mechanical or thermal excitation [20–22]. Although
optical actuation may be used, its application for use in vivo
islimited.Moreover, magneticactuation could useremotely
applied ac and dc ﬁelds to regulate intracellular temperature
[23], control the release of drug from the tunable excipient
by regulating swelling/shrinkage behavior [12] and manip-
ulate cellular functions (e.g., axon growth) within tissues
[17]. Thus, using tunable PEG derivatives to encapsulate
nanomagnets may facilitate the simultaneous regulation of
localized temperature and sustained release of pharmaceu-
ticals to the targeted cells in clinical practice.
In this study, we report synthesis and actuation of low
toxicity magnetic nanospheres and assessed their effect on
PC12 cell viability and morphology. Copolymers of 2-(2-
methoxyethoxy)ethyl methacrylate and oligo(ethylene
glycol) methacrylate (PEGETH2MA-co-PEGMA) based
hydrogels were synthesized to encapsulate ferromagnetic
nano-particles. The polymeric shell acts as the reservoir of
the drug molecules, while the magnetic core acts as nano-
source of heat when exposed to the ac magnetic ﬁeld. To
our knowledge, this is the ﬁrst time that ac ﬁeld modulated
remote actuation, model drug release and cytotoxicity is
assessed for monodisperse, novel nanospheres that are
made of all biocompatible and tunable polymers.
Experimental Techniques
Nanosphere Synthesis
We synthesized ferromagnetic nanoparticles (Fe3O4)
encapsulated within the thermo-activated polymer network
of PEGETH2MA-co-PEGMA using free radical polymeri-
zation (Scheme 1). In 200 mL of deionized (DI) water were
dissolved 6.4 g of PEGETH2MA (Mn * 246 g mol
-1,
Aldrich), 1.57 g PEGMA (Mn * 300 g mol
-1, Aldrich),
0.12 g Fe3O4, 0.064 g sodium dodecyl sulfate (SDS) and
4.6010
-4 mol of ethylene glycol dimethacrylate (EGDMA
97%, Fluka). The solution was purged with nitrogen gas for
40 min at 70 C. Ammonium persulfate (APS, 0.20 g),
which was dissolved in 5 mL of water, was then added to
initiate the emulsion copolymerization. The reaction lasted
for 12 h under nitrogen gas bubbling atmosphere. The
nanospheres were puriﬁed via a dialysis tube (MW cut-off
13, 000) against water for 7 days at room temperature,
while the de-ionized water was exchanged twice a day, and
collected by ultra centrifugation. Thermogravimetric anal-
ysis (TGA) was performed to quantify the polymer and
nanomagnet concentration after synthesis. Vitamin B12
(MW 1356) was used as model drug for ac ﬁeld modulated
release demonstration. Magnetic nanospheres and the con-
trol polymeric nanoparticles (without magnetic core) are
used for release experiment. Aqueous solution of vitamin
B12 (20 mg/mL) was added to the freeze-dried nanospheres.
The solution was stirred for 8 h at 25 C. Drug loaded
particles were collected by ultra centrifugation. The release
behavior was studied in insulated plastic reaction vessels
containing the nanosphere solution. Two separate condi-
tions were maintained: (a) ac ﬁeld exposure (100 Oe,
150 kHz), and (b) dc ﬁeld exposure (100 Oe, 0 Hz). The
supernatant was collected at every time point following the
ac/dc ﬁeld exposure, and the particles are re-dispersed.
Time dependent release was quantiﬁed as mass released at
time t,M t, over the total mass released, Mcum (96 h) using a
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123UV–Vis spectrometer. To minimize Joule heating, ac ﬁeld
was switched on for 20 min, following 40 min off cycles.
For uptake assessment, ﬂuorescent nanospheres were syn-
thesized by conjugating with methacryloxyethyl thiocar-
bamoyl rhodamine B ﬂuorescent monomers (Polysciences,
Inc., emission: 570 nm) during the copolymerization reac-
tion. Fluorescence intensity is easily varied by adjusting the
amount of ﬂuorescent monomer during reaction and in this
study, 1 mg of monomer is added per 6 gm of copolymer
content. Any unreacted ﬂuorescent monomer was removed
by dialysis for 7 days.
Scanning and Transmission Electron Microscopy
Sphere morphology was assessed using an FEI QUANTA
200 scanning electron microscope (SEM). A Philips EM
420 transmission electron microscope (TEM) was used to
simultaneously observe polymer encapsulation and the
embedded magnetic nanoparticles (core–shell structure).
Cryo-immobilization was performed to prevent the nano-
spheres from collapsing during electron microscopy.
Accelerating voltage during SEM imaging was kept
between 5 and 20 kV; TEM analysis was performed with
120 kV electron beam.
Light Scattering and Magnetic Measurements
For the dynamic light scattering (DLS) experiment, a laser
light scattering spectrometer (ALV, Germany) equipped
with an ALV-5000 digital time correlator was used with a
helium–neon laser (Uniphase 1145P, wavelength of
632.8 nm) as the light source. The hydrodynamic radius
distribution of the nanospheres in water was measured at a
scattering angle of 60. A homemade magnetic ﬁeld
generator was designed to extract the AC ﬁeld induced
heating response. This device consists of an AC signal
generator, a power ampliﬁer, and a copper coil (diameter
25 mm, coil quality factor *70). The coil was an element
of a resonant RLC circuit with a self-inductance of 48 lH.
The ﬁeld strength was calculated using a high-frequency
current probe (Tektronix) and an oscilloscope (Agilent).
Custom software (written in LabView) controls the signal.
Magnetic property [M(H)] of the nanospheres was mea-
sured using a Lakeshore model 7300 vibrating sample
magnetometer (VSM) at ambient temperature.
Cell Culture and Treatment
PC12 rat pheochromocytoma cells (ATCC, Manassas, VA)
were used to assess nanosphere biocompatibility. Cells
were routinely cultured at 37 Ci n5 %C O 2 in F-12
nutrient mixture with Kaighn’s modiﬁcation (F12 K) con-
taining 2.5% fetal bovine serum and 15% horse serum
(both from Invitrogen, Carlsbad, CA). For experiments,
cells were plated at 10,000 cells/cm
2 on glass coverslips in
24-well tissue culture plates and allowed to grow for 48 h.
Cultures were washed twice with phosphate buffered saline
(PBS) and placed into serum- and phosphate-free HEPES-
buffered Dulbecco’s modiﬁed Eagle’s medium (DMEM,
Invitrogen, Carlsbad, CA) to prevent particle aggregation.
Nanospheres were added at ﬁnal iron concentrations
(assessed by TGA analysis) of 0, 0.34, 3.4, 6.0 or 16 mM
for 48 h.
Assessment of Particle Internalization
PC12 cells were exposed for 48 h at 37 C to ﬂuorescent
nanospheres containing magnetic nanoparticles at an iron
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123concentrationof3.4 mM.CultureswerewashedwithPBSto
removeextracellularnanoparticles,andcellswereincubated
for24morehoursat37 C.Cultureswereﬁxedfor20 minin
4.0% paraformaldehyde and 2.0% glutaraldehyde in PBS at
room temperature. Images were captured through a 649
objective in differential interference contrast (DIC) and te-
tramethylrhodamineisothiocyanate(TRITC,Ex = 568 nm,
Em = 585/40 nm) channels using a Zeiss Axiovert 200 M
microscope (Zeiss, Thornwood, NJ) ﬁtted with a Yokogawa
CSU-10 confocal scanner and a Hamamatsu camera (McB-
ain Instruments, Simi Valley, CA).
Assessment of Cell Viability
After exposure to magnetic nanospheres, cells were washed
twice in PBS and viability was assessed using the Live/
Dead viability/cytotoxicity assay (Invitrogen, Carlsbad,
CA), according to the manufacturer’s directions. In brief,
cultures were double-labeled with calcein AM, which
permeates cell membranes and becomes ﬂuorescent when
exposed to esterase activity in living cells, and ethidium
homodimer-1 (EthD1), which is excluded by the plasma
membrane from living cells but crosses the compromised
membrane of damaged cells to bind nucleic acids and
ﬂuoresce. Digital images were captured through a 109
objective on a Zeiss Aviovert 200 M microscopy (Zeiss,
Thornwood, NJ) in ﬂuorescein isothiocyanate (FITC,
Ex = 480/30 nm, Em = 535/40 nm) and TRITC
(Ex = 540/25 nm, Em = 605/55 nm) channels for calcein
AM and EthD1, respectively. Only non-aggregated single
cells (at least 300 cells/condition) were quantiﬁed, and the
percent of viable cells was calculated. Signiﬁcant differ-
ences between magnetic nanospheres containing different
concentrations of iron were determined by ANOVA with
subsequent Tukey post-hoc tests. Nuclear morphology was
assessed using confocal images captured through a 649
objective from cells labeled with 40,6-diamidino-2-pheny-
lindole (DAPI, Ex = 405 nm, Em = 450/35 nm), follow-
ing exposure to nanospheres containing magnetic
nanoparticles at different concentrations of iron.
Assessment of Cell Morphology, Cytoskeleton
and Neurite Outgrowth
Following nanosphere exposure, cultures were washed
twice with PBS and placed into serum-free F-12 K for 72 h
with or without 100 ng/mL nerve growth factor b subunit
(b-NGF, Sigma–Aldrich, St. Louis, MO) being added daily.
Cultures were ﬁxed in 4.0% paraformaldehyde and 2.0%
glutaraldehyde in PBS, washed twice in PBS, and blocked
for 30 min in PBS containing 1.5% normal donkey serum
and 0.1% Triton X-100 at room temperature. Samples were
double labeled for ﬁlamentous actin and tubulin by
sequential exposure to 3.3 lM Texas Red-X phalloidin
(30 minutes, Invitrogen, Carlsbad, CA) and rabbit anti-bIII
tubulin(1:200,overnight,Abcam,CambridgeMA).Tubulin
immunoreactivity was visualized by Alexaﬂuor 488-conju-
gated donkey anti-rabbit secondary antibodies (1:200, 1 h,
Invitrogen, Carlsbad, CA). Digital images were captured
thougha409objectiveusingDICoptics,andthrougha649
objective in TRITC (Ex = 568 nm, Em = 585/40 nm) and
FITC (Ex = 488 nm, Em = 520/35 nm) channels on a
Zeiss Axiovert 200 M microscope with confocal attach-
ments (McBain Instruments, Simi Valley, CA).
Neurite outgrowth was assessed using the percent of
neurite-bearing cells, determined from phase contrast
images (ﬁve images/condition/experiment) captured
through a 409 objective on a Zeiss Axiovert 200 M
microscope. For this analysis, a neurite was deﬁned as a
cellular extension that exceeded 10 lm. Only non-aggre-
gated cells where the cell and all its neurites were included
in the image were quantiﬁed, and imaged ﬁelds were sys-
tematically selected from each quadrant and the center of
each coverslip to ensure a representative sample. Differ-
ences between experimental conditions were determined
by ANOVA with subsequent Tukey post-hoc test using a
signiﬁcance level of a = 0.05.
Results and Discussion
It was important to design a system where the polymer
encapsulates the magnetic nanoparticles to facilitate solu-
bility and bioavailability and also provides the potential to
conjugate bioactive peptides, antibodies, oligonucleotides
or drugs. Thus, a key feature was to design a PEG-based
system with a tunable LCST close to physiological tem-
perature. Based on previous reports [17, 18], we chose a
molar ratio of PEGMA to PEGETH2MA of 20%. Unlike
single domain crystals, multi-domain magnetic particles
exhibit primarily hysteresis loss-induced heating inside the
ac ﬁeld exposure with low frequency. Hysteresis loss
induced heating is preferred over relaxation loss because
the former is easier to tune by the controlled modulation of
the oscillating magnetic ﬁeld, especially considering the
sharp hydrodynamic radius change that may occur around
the LCST and severely impact the Brownian relaxation
loss. To maximize the energy absorption, nanomagnet size
was chosen to be in the range of 25–30 nm, close to the
ferromagnetic exchange length (27 nm) for magnetite [24].
Physiochemical Characterization of Magnetic
Nanospheres
The nanospheres exhibited good colloidal stability in
aqueous solution with no obvious precipitation after
198 Nanoscale Res Lett (2010) 5:195–204
123several days. We initially assessed particle size and mor-
phology using SEM. Spherical particles were observed
(Fig. 1a), and the mean diameter was found to be
315 ± 23 nm. No magnetic nanoparticles were observed
on the surface of the nanospheres, which is an indirect
proof of polymer encapsulation. The lower electron beam
energy (5–30 kV) of SEM imaging was insufﬁcient to
penetrate the outer polymer layer, so we directly assessed
particle encapsulation by TEM. At an accelerating voltage
of 90 kV, electrons were able to pierce through the outer
polymer shell. The resulting TEM micrographs revealed
that the nanomagnets were mostly concentrated near the
center of the nanospheres (Fig. 1b). The individual parti-
cles were located near each other, but they were separated
and did not agglomerate. We interpret these results as
validation that the synthesis did indeed produce nano-
spheres with a hydrophobic core that had limited or no
particle agglomeration (even at higher concentrations),
which would have resulted in subsequent reduction in
coercivity.
The temperature dependence of normalized hydrody-
namic radii (Rh) of the magnetic nanospheres was probed
by performing the DLS measurement (Fig. 2). Here, the
radii [Rh(T)] are divided by the value at 22 C[ Rh(22)], and
the molecular weight of PEGMA is ﬁxed at 300 Da. The
volumetric transition occurred between 31 and 41 C and
included a sharper change or LCST at around 36 C. The
broader transition range was attributed to the free radical
polymerization process, where polymer chains are initiated
all along the reaction, and therefore strong chain-to-chain
deviations of composition can be expected. This transition
range is broader than that of the PNIPAM nanospheres,
which have homogeneous composition and therefore, a
sharp transition [25]. Volumetric change is seen to be
unaffected due to nanomagnet doping compared to the non-
magnetic PEG nanospheres having similar compositions,
justifying the use of optimal concentration of magnetic
particles. LCST of the nanospheres can be elevated/low-
ered to a desired temperature based on PEGMA molecular
weight and molar ratio and currently being investigated.
Magnetic properties of the doped PEGETH2MA-co-PEG-
MA nanosphere aqueous dispersion (10 wt% polymer
concentration; i.e., 3.5 mg/mL Fe3O4, determined by TGA
analysis) were probed by performing the VSM measure-
ments (Fig. 2, Inset). The hysteresis response reveals the
ferromagnetic characteristics of the nanospheres. From the
TEM micrographs, we observed that the nanomagnets did
not agglomerate after repeated heating cycles, possibly
because of the lower residual magnetism (0.314 9 10
-2
emu/gm) of the particles.
Response to Alternating Magnetic Field and Drug
Release
We next measured the remote heating response of the
nanospheres in an ac magnetic ﬁeld (125 Oe, 120 kHz).
Temperature inside the insulated plastic reaction vessels
containing the nanosphere solutions was monitored by a
ﬁber optic temperature sensor (Photon Control Inc.,).
Copolymer concentrations were varied from 10 to 0.1 wt%,
resulting in nanomagnet concentration of 3.5 to 0.035 mg/
mL (*45–0.45 mM Fe). Upon application of the ﬁeld, the
measured temperature of the nanosphere solutions
increased in a concentration-dependent manner and
reached a near steady state after *30 min (Fig. 3a). For
any speciﬁc concentration of nanomagnets, similar tem-
perature regulation capability is achieved as a function of
ac ﬁeld intensity. As speculated from the minor hysteresis
loops, the effective heating is observed only above a
threshold ﬁeld (*37 Oe, not shown here). Finally, ac ﬁeld
dependent release of vitamin B12 is demonstrated in
Fig. 3b. Oscillating ﬁeld induced heating and subsequent
shrinkage of the hydrogel network led to enhanced release
of the loaded drug from the magnetic nanospheres. How-
ever, ac ﬁeld was unable to heat the control nanospheres
and did not cause accelerated release from them. Moreover,
it is also observed that the applied dc ﬁeld had minimal
effect on the release proﬁle for both magnetic and the
Tunable  excipient
Magnetic NPs
(a)  (b)
Fig. 1 a SEM, and b TEM
micrographs of the magnetic
nanospheres; nanomagnets are
not visible through the polymer
layer in SEM images, while the
TEM micrograph (90 kV)
captures the polymer
encapsulation and the embedded
nanoparticles simultaneously
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123control particles. As the nanosphere temperature can be
tailored by controlled modulation of ﬁeld intensity and
nanomagnet loading, we interpret these results to indicate
that the system may be precisely manipulated using
external ac magnetic ﬁelds to alter the release proﬁle or
sequential release.
Magnetic Nanosphere Internalization into Neuron-Like
Cells
To affect cellular functions, magnetic nanospheres must
gain entry into cells. We assessed cellular uptake using
ﬂuorescent magnetic nanospheres and confocal micros-
copy. Cells not exposed to nanospheres displayed mor-
phology typical of PC12 cells (Fig. 4a) and had minimal
ﬂuorescence in confocal sections taken through the center
of each cell (Fig. 4b). In comparison, exposure to magnetic
nanospheres did not alter cell morphology (Fig. 4c). Sim-
ilar to previous results [26–28], ﬂuorescent nanospheres
were readily internalized (Fig. 4d). Interestingly, the pat-
tern of internalization in the current study was more
indicative of a cytosolic distribution, compared to the
typical punctuate endosome distribution seen in the earlier
reports. It is possible that 48 h of exposure to magnetic
nanospheres allowed translocation of the nanospheres from
endocytotic vesicles to the cytosol. However, endocytotic
distribution was still observed in non-neuronal cells 3 days
after nanoparticle exposure [28], perhaps reﬂecting a cell
type-speciﬁc response. In this analysis, we observed that
nearly 100% of the cells internalized magnetic nanospheres
within 48 h. That the synthesized nanospheres are so
readily internalized has important implications for the
potential of this system to be useful in biomedical thera-
peutics. In addition, these results also indicate the ease of
derivatizing the polymer shell, potentially providing an
efﬁcient method to target the nanosphere to particular cells.
For instance, by selecting a proper initiator and surfactant,
it is possible to synthesize nanospheres with amino or
carboxyl functional groups to allow covalent attachment of
peptides at either the carboxy or amino termini. Targeted
delivery could be achieved by attaching a peptide ligand
for a neuron-speciﬁc receptor (e.g., attaching the b subunit
of nerve growth factor for targeting trkA expressing neu-
rons), similar to strategies previously reporting for target-
ing nanoparticle systems to particular cell types [29–31]. In
addition, this could allow measured release of incorporated
drugs or peptides using oscillating magnetic ﬁelds, creating
highly diverse therapeutic potential for the synthesized
system [27, 32].
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123Magnetic Nanospheres are Minimally Toxic
to Neuron-Like Cells
To be useful in biomedical applications, the constructed
nanospheres must have low toxicity and little innate bio-
reactivity. We assessed the cytotoxicity of the magnetic
nanospheres using a Live/Dead assay. In this assessment,
living cells incorporated calcein AM and remained imper-
meable to ethidium homodimer 1 (EthD1), thereby exhib-
iting green ﬂuorescence. Dead or dying cells allowed EthD1
to cross their compromised membranes and exhibited red
ﬂuorescence. Fluorescent images of PC12 cells not exposed
to magnetic nanospheres had a very low basal level of cell
death (Fig. 5a). Comparable levels of cell death were seen
in cells exposed for 48 h to nanospheres containing mag-
netic nanoparticles corresponding to 3.4 mM iron (Fig. 5b).
For nanospheres containing higher levels of magnetic
nanoparticles (e.g., an iron concentration of 16 mM),
toxicity increased (Fig. 5c). Quantiﬁcation (Fig. 5d)
indicated a signiﬁcant effect of magnetic nanoparticle
concentration on cell viability (F3,11 = 22.741, p =
0.001), but conﬁrmed there was no difference between
cells exposed to nanospheres with iron concentrations up
to 3.4 mM (p[0.98). However, cell viability was
decreased by nanospheres containing magnetic nanopar-
ticles with 16 mM iron concentration (p = 0.001). Based
on prior work using magnetic nanoparticles, we assume
that cell death occurred through an apoptotic mechanism.
We did not completely analyze this, but did assess nuclear
morphology and found little fragmentation and blebbing or
DNA condensation in cells not exposed to magnetic nan-
ospheres (Fig. 5e) or exposed to nanospheres containing
magnetic nanoparticles at an iron concentration of 3.4 mM
(Fig. 5f). Nuclear changes were abundant with nano-
spheres containing high levels of magnetic nanoparticles
(16 mM iron, data not shown). These results suggest the
Fig. 4 Cellular uptake of
magnetic nanospheres by PC12
cells. Representative
(a) differential interference
contrast (DIC) and
corresponding (b) confocal
images of PC12 cells not
exposed to magnetic
nanospheres. Representative
(c) DIC and corresponding
(d) confocal images of cells
exposed to ﬂuorescent magnetic
nanospheres showing abundant
internalization into cells. Scale
bar in (b) = 10 lm and is valid
for all images
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123constructed nanosphere system assessed here had
decreased cellular toxicity and induction of apoptosis
compared to magnetic nanoparticles coated with PNIPAM
or dimercaptosuccinic acid (DMSA) [14], or polyethy-
lenoxide (PEO) triblock copolymers [33].
Magnetic Nanoparticles Minimally Affect Morphology
and Neurite Outgrowth
Because central nervous system axons do not regenerate to
an appreciable extent after damage [1], one application of
Fig. 5 Magnetic nanospheres have minimal cellular toxicity. Repre-
sentative digital image of PC12 cells either not exposed (a), or
exposed to magnetic nanospheres with iron concentrations of
(b) 3.4 mM or (c) 16 mM for 48 h and double labeled with calcein
AM (green) to show living cells and ethidium homodimer-1 (EthD1,
red) to label dead or dying cells. Scale bar in (c) = 50 lm, and is
valid for (a), (b) and (c). d Quantiﬁcation revealed little cell toxicity
up to 3.4 mM iron. Data are means ± standard deviations from three
separate experiments, * p = 0.001 compared to cells not exposed to
magnetic nanospheres (ANOVA and subsequent Tukey’s post-hoc).
Representative images show intact nuclei with little evidence of
fragmentation, condensation or blebbing for cells (e) not exposed or
(f) exposed to nanospheres containing 3.4 mM iron. Scale bar in
(f) = 10 lm, and is valid for (e) and (f)
Fig. 6 Cells maintain normal morphology after exposure to magnetic
nanospheres. Representative differential interference contrast (DIC)
images of cells not exposed to magnetic nanospheres show typical
morphology for PC12 cells (a) not treated or (b) treated daily with
100 ng/mLnervegrowthfactor(NGF)for72 h.Normalmorphologyis
maintainedwhencellsareexposedtomagneticnanospheresand(c)not
treated or (d) treated with NGF. Compared to cells not exposed to
magnetic nanospheres and (e) not treated or (f) treated with NGF, cells
exposed to magnetic nanospheres in the (g) absence or (h) presence of
NGF have similar microtubule (green) and actin ﬁlament (red)
cytoskeletal arrangements. Scale bar in (d) = 10 lm and is valid for
(a)through(d).Scalebarin(h) = 10 lmandisvalidfor(e)through(h)
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123the synthesized nanosphere system might be in the thera-
peutic manipulation of axon extension. If the nanospheres
do not inhibit the extension of cellular processes, they hold
promise for this application. We began to assess the
potential use of the synthesized nanospheres for manipu-
lating axon extension using PC12 cells, a neuronal model
that extends neurites in response to exogenous addition of
nerve growth factor (NGF). PC12 cells not exposed to
magnetic nanospheres exhibited little formation of neurites
in the absence of NGF, showing a spreading morphology
with abundant lamellipodia (Fig. 6a). In contrast, cells
exposed to NGF displayed a neuron-like morphology with
1–2 neurites/cell (Fig. 6b). Exposure to magnetic nano-
spheres containing nanoparticles at 3.4 mM iron did not
alter cell morphology in the absence (Fig. 6c) or presence
(Fig. 6d) of NGF. Because neuron structure is determined
by the arrangement of cytoskeletal microtubules and actin
ﬁlaments, we next assessed the effect of magnetic nano-
spheres on PC12 cytoskeleton. For cells not exposed to
magnetic nanospheres, typical arrangements of cytoskeletal
elements were observed. Here, tubulin was abundant in the
central regions of cells, and actin ﬁlaments were mainly
localized to the cell cortex for rounder cells observed in the
absence of NGF (Fig. 6e) and for cells extending neurites
in the presence of NGF (Fig. 6f). Cytoskeletal arrange-
ments were similar for cells exposed to magnetic nano-
spheres (3.4 mM iron) in both the absence (Fig. 6g) and
presence (Fig. 6h) of NGF. However, it may be possible
that actin ﬁlament concentration was slightly increased in
cells exposed to magnetic nanospheres (compare Fig. 6
(e, f) with Fig. 6 (g, h)). These results stand in contrast to
the decreased actin ﬁlament content seen with DMSA
coated magnetic nanoparticles [14]. Thus, it appears that
the constructed nanosphere system has no detrimental
effects on cell morphology and cytoskeleton, and may
enhance the formation of actin ﬁlaments.
The few effects on cell morphology indicate promise
for the synthesized system for manipulating axon
Fig. 7 Magnetic nanospheres
do not inhibit neurite outgrowth.
Compared to representative
phase contrast images of PC12
cells not exposed to magnetic
nanospheres and either (a) not
treated or (b) treated daily with
100 ng/mL nerve growth factor
(NGF), cells exposed to
magnetic nanospheres with an
iron concentration of 6.0 mM
display similar morphology in
the (c) absence or (d) presence
of NGF. Scale bar in
(d) = 10 lm, and is valid for
(a) through (d). e Quantiﬁcation
of the percent of neurite bearing
cells shows similar neurite
outgrowth for cells either not
exposed or exposed to magnetic
nanospheres at iron
concentrations of 0.34 and
6.0 mM and treated with NGF,
all of which increased neurite
outgrowth compared to cells not
treated with NGF. Data in
(e) are means ± standard
deviations from three separate
experiments, * p = 0.001
compared to cells not treated
with NGF (ANOVA with
subsequent Tukey post-hoc test)
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123regeneration. However, if the nanospheres adversely
affect neurite outgrowth, their therapeutic potential is
decreased. Qualitative assessment from phase-contrast
images of cells not exposed to magnetic nanospheres
showed little neurite outgrowth in the absence of NGF
(Fig. 7a), whereas daily treatment with 100 ng/mL NGF
led to cells that readily extended neurites and exhibited
the formation of cellular contacts (Fig. 7b). Similar levels
of neurite extension were seen in cells exposed to nano-
spheres containing magnetic nanoparticles with an iron
concentration of 6.0 mM for 48 h prior to 72 h without
(Fig. 7c) or with 100 ng/mL NGF (Fig. 7d). In the latter,
cells also formed cell to cell contacts. These results
indicated that exposure to non-toxic levels of magnetic
nanospheres did not inhibit the elaboration of neurites. An
exciting application of this system is its implementation
to enhance axon growth and manipulate axon trajectories
in combination with endogenous responses to magnetic
ﬁelds [2–4]. We are currently assessing baseline and
magnetic ﬁeld-induced responses of several neuronal
models to the nanospheres.
Conclusions
In summary, we report the synthesis, actuation and dose-
dependent modulation of a multifunctional nano-scale
system consisting of all FDA-approved bio-polymers.
Based on these results, we conclude that the designed
nanomagnets possess dual capability of regulating tem-
perature and tuning size, i.e., the mesh density by remote
controlled actuation. These special features carry the
potential for synergistic application of heat and sustained
release of small molecules in therapeutics. Moreover,
compared to currently available systems, cytotoxicity is
remarkably reduced by the stealth polymer encapsulation
around the magnetic core and allowing higher intracellular
concentrations of magnetic nanoparticles. One exciting
application for this system may be using either unaltered or
derivatized nanospheres in conjunction with magnetic
ﬁelds to manipulate axon growth. The neurite growth
pattern seen at high nanosphere concentrations is especially
promising for further studies with effect on primary neu-
rons in terms of axon regeneration following nervous
system injury.
Acknowledgments Supported by the TWU Department of Biology,
the SEMO Physics and Engineering Physics Department, and grants
from the TWU Research Enhancement and Summer Stipend pro-
grams (to DLH), the Texas Higher Education Coordinating Board
Closing the Gaps program (to DLH), and the SEMO Grants and
Research Funding Committee (to SG). We sincerely appreciate
Dr. Zhibing Hu’s generosity for laboratory access.
References
1. R.L. Ruff, L. McKerracher, M.E. Selzer, Ann. NY. Acad. Sci.
1142, 1–20 (2008)
2. M.Y. Macias, J.H. Battocletti, F.A. Pintar, D.J. Maiman, Bio-
electromagnetics 21, 272–286 (2000)
3. C.D. McCaig, A.M. Rajnicek, B. Song, M. Zhao, Physiol. Rev.
85, 943–978 (2006)
4. S. Kim, W.S. Im, L. Kang, S.T. Lee, K. Chu, B.I. Kim, J. Neu-
rosci. Meth. 174, 91–96 (2008)
5. D.A. La Van, T. McGuire, R. Langer, Nat. Biotechnol. 21, 1184–
1191 (2003)
6. C.M.Niemeyer,Angew.Chem.Int.Ed.Engl.40, 4128–4158 (2001)
7. A.P. Alivisatos, Nat. Biotechnol. 22, 47–52 (2004)
8. A.J. DeMello, Nature 442, 394–402 (2006)
9. J. Lutz, S. Stiller, A. Hoth, L. Kuafner, R. Cartier, Biomacro-
molecules 7, 3132–3138 (2006)
10. A. Peppas, J. Hilt, A. Khademhosseini, R. Langer, Adv. Mater.
18, 1345–1360 (2006)
11. R. Bashir, Adv. Drug. Deliver. Rev. 56, 1565–1586 (2004)
12. T. Liu, S. Hu, K. Liu, D. Liu, S. Chen, J. Magn. Magn. Mater.
304, e397 (2006)
13. D.C. Harsh, S.H. Gehrke, J. Controlled Release 17, 175 (1991)
14. T.R. Pisanic II, J.D. Blacwell, V.I. Shubayev, R.R. Finones, S.
Jin, Biomaterials 28, 2572–2581 (2007)
15. F. Mohamed, P. Marchettini, O.A. Stuart, M. Urano, P.H. Sug-
arbaker, Ann. Surg. Oncol. 10, 463–468 (2003)
16. Z.B. Hu, Y. Chen, C. Wang, Y. Zheng, Y. Li, Nature 393, 149–
152 (1998)
17. T. Cai, M. Marquez, Z. Hu, Langmuir 23, 8663–8666 (2007)
18. J. Lutz, A. Hoth, Macromolecules 39, 893–896 (2006)
19. S. Ghosh, C. Yang, T. Cai, Z. Hu, A. Neogi, J. Phys. D Appl.
Phys. 42(13), 135501 (2009) (8 pp)
20. D.T. Eddington, D.J. Beebe, J. Microelectromech. S. 103, 586–
593 (2004)
21. Q. Yu, J.M. Bauer, J.S. Moore, D.J. Beebe, Appl. Phys. Lett. 78,
2589–2591 (2001)
22. S.R. Sershen, G.A. Mensing, N.J. Halas, D.J. Beebe, J.L. West,
Adv. Mater 17, 1366–1368 (2005)
23. N.K. Prasad, K. Rathinasamy, D. Panda, D. Bahadur, J. Mater.
Chem. 17, 5042–5051 (2007)
24. M. Ma, Y. Wu, J. Zhou, Y. Sun, Y. Zhang, N. Gu, J. Magn.
Magn. Mater. 268, 33–39 (2004)
25. B. Garner, T. Cai, S. Ghosh, Z. Hu, A. Neogi, Appl. Phys. Exp. 2,
057001–057003 (2009)
26. F. Bertorelle, C. Wilhelm, J. Roger, F. Gazeau, C. Me ´nager, V.
Cabuil, Langmuir 22, 5385–5391 (2006)
27. L. Hasadsri, J. Kreuter, H. Hattori, T. Iwasaki, J.M. George, J.
Biol. Chem. 284, 6972–6981 (2009)
28. C. Yu, J. Zhao, Y. Guo, C. Lu, X. Ma, Z. Gu, J. Biomed. Mater.
Res. 87A, 364–372 (2008)
29. S.A. Townsend, G.D. Evrony, F.X. Gu, M.P. Schulz, R.H. Brown
Jr, R. Langer, Biomaterials 28, 5176–5184 (2007)
30. D. Demirgo ¨z, A. Garg, E. Kokkoli, Langmuir 24, 13518–13524
(2008)
31. L. Yang, H. Mao, Y.A. Wang, Z. Cao, X. Peng, X. Wang, H.
Duan, C. Ni, Q. Yuan, G. Adams, M.Q. Smith, W.C. Wood, X.
Gao, S. Nie, Small 5, 235–243 (2009)
32. Y. Cho, R. Shi, A. Ivanisevic, R.B. Borgens, Nanotechnol. 20,
2757102U (2009)
33. O. Ha ¨feli, J.S. Rifﬂe, L. Harris-Shekhawat, A. Carmichael-Bar-
anauskas, F. Mark, J.P. Dailey, D. Bardenstein, Mol. Pharm.
(2009). doi: 10.1021/mp900083m
204 Nanoscale Res Lett (2010) 5:195–204
123